Renal Cell Carcinoma
摘要
18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography has a limited role in renal cell carcinoma (RCC). This chapter will answer common questions about FDG PET and non-FDG PET tracers and their clinical applications, advantages, and limitations in RCC cancer.